These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17945460)

  • 1. An update on the diagnosis and treatment of early Lyme disease: "focusing on the bull's eye, you may miss the mark".
    Stonehouse A; Studdiford JS; Henry CA
    J Emerg Med; 2010 Nov; 39(5):e147-51. PubMed ID: 17945460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical erythema migrans in patients with PCR-positive Lyme disease.
    Schutzer SE; Berger BW; Krueger JG; Eshoo MW; Ecker DJ; Aucott JN
    Emerg Infect Dis; 2013 May; 19(5):815-7. PubMed ID: 23697348
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond the bull's eye: Recognizing Lyme disease.
    Chaaya G; Jaller-Char JJ; Ali SK
    J Fam Pract; 2016 Jun; 65(6):373-9. PubMed ID: 27474818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erythema migrans as a patognomic symptom of lyme disease].
    Moniuszko A; Pancewicz S; Czupryna P; Dunaj J; Guziejko K; Zajkowska J
    Pol Merkur Lekarski; 2013 Oct; 35(208):230-2. PubMed ID: 24340896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple erythema migrans and facial nerve paralysis: clinical manifestations of early disseminated Lyme borreliosis].
    Braun SA; Baran AM; Boettcher C; Kieseier BC; Reifenberger J
    Hautarzt; 2014 Apr; 65(4):268-71. PubMed ID: 24700023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial.
    Stupica D; Velušcek M; Blagus R; Bogovic P; Rojko T; Cerar T; Strle F
    J Antimicrob Chemother; 2018 May; 73(5):1352-1358. PubMed ID: 29385444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up.
    Eliassen KE; Reiso H; Berild D; Lindbæk M
    Clin Microbiol Infect; 2018 Dec; 24(12):1290-1296. PubMed ID: 29505880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Lyme Disease Guidelines for Erythema Migrans Lesions Miss the Mark.
    Maloney EL
    Am J Med; 2022 Feb; 135(2):e55. PubMed ID: 35148821
    [No Abstract]   [Full Text] [Related]  

  • 9. Pregnant women with erythema migrans and isolation of borreliae from blood: course and outcome after treatment with ceftriaxone.
    Maraspin V; Ružić-Sabljić E; Pleterski-Rigler D; Strle F
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):446-8. PubMed ID: 21917394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple erythema migrans--manifestation of systemic cutaneous borreliosis.
    Egberts F; Möller M; Proksch E; Schwarz T
    J Dtsch Dermatol Ges; 2008 May; 6(5):350-3. PubMed ID: 18201222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocol.
    Torbahn G; Hofmann H; Allert R; Freitag MH; Dersch R; Fingerle V; Sommer H; Motschall E; Meerpohl JJ; Schmucker C
    Syst Rev; 2016 May; 5():73. PubMed ID: 27142846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyme disease vs Baggio-Yoshinari syndrome in a returned traveller from Brazil.
    Vien VP; Bassi R; Maxim T; Bogoch II
    J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28931143
    [No Abstract]   [Full Text] [Related]  

  • 13. Lyme borreliosis: current issues in diagnosis and management.
    O'Connell S
    Curr Opin Infect Dis; 2010 Jun; 23(3):231-5. PubMed ID: 20407371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
    Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying erythema migrans rash in patients with Lyme disease.
    Dardick K
    Am Fam Physician; 2014 Mar; 89(6):424. PubMed ID: 24695559
    [No Abstract]   [Full Text] [Related]  

  • 16. The Spectrum of Erythema Migrans in Early Lyme Disease: Can We Improve Its Recognition?
    Schotthoefer AM; Green CB; Dempsey G; Horn EJ
    Cureus; 2022 Oct; 14(10):e30673. PubMed ID: 36439577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and serological features of patients with suspected Lyme borreliosis.
    Santino I; Longobardi V
    Int J Immunopathol Pharmacol; 2011; 24(3):797-801. PubMed ID: 21978712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of Lyme disease.
    Bratton RL; Whiteside JW; Hovan MJ; Engle RL; Edwards FD
    Mayo Clin Proc; 2008 May; 83(5):566-71. PubMed ID: 18452688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional outcomes in patients with Borrelia burgdorferi reinfection.
    Jares TM; Mathiason MA; Kowalski TJ
    Ticks Tick Borne Dis; 2014 Feb; 5(1):58-62. PubMed ID: 24215678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of erythema migrans with doxycycline for 10 days versus 15 days.
    Stupica D; Lusa L; Ruzić-Sabljić E; Cerar T; Strle F
    Clin Infect Dis; 2012 Aug; 55(3):343-50. PubMed ID: 22523260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.